Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지

The Expression of Hypoxia Inducible Factor-1 $\alpha$ by Desferrioxamine Induces Radioresistance in Mouse Hepatoma Cell Line

쥐의 간암 세포에서 Desferrioxamine에 의해 유도된 Hypoxia Inducible Factor-1 $\alpha$가 방사선 저항성을 초래함

  • Kwon, Byung-Hyun (Department of Radiation Oncology, Pusan National University School of Medicine)
  • 권병현 (부산대학교 의과대학 방사선종양학교실)
  • Published : 2004.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: It is well known that the radiosensitivity of tumor cells can be significantly reduced under hypoxic conditions. Hypoxia-inducible factor-1 $\alpha$ (HIF-1 $\alpha$) plays a pivotal role in the essential adaptive responses to hypoxia. Therefore this study investigated the relationship between HIF-1 $\alpha$ expression and radiosensitivity. M Mouse hepatoma cell line hepafcic7 and HIF-1 $\beta$-deficient mutant cell line hepa1C4 were used to analyze the role of HIF-1 a. on radiosensitivity. These cells were exposed for 6 h to desferrioxamine (DFX) before radiation. HIF-1$\alpha$. expression was examined by Western blot. Apoptosis was assessed by DNA fragmentation, propidium iodide staining, and apoptotic cell death detection ELISA kit. Radiation sensitivity was determined using MTT assay. The radiobioiogical parameters, surviving fractions at 2 Gy and 8 Gy, and mean inactivation dose (MID) from the linear-quadratic model were used to assess radiation sensitivity in the statistical analyses. Results: The expression of HIF-1 $\alpha$. was Increased, whereas apoptosis was decreased, by radiation In the presence of DFX In hepal cl c7, but not In hepal C4. The radlosensitivity of hepal C4 cells was not significantly affected by DFX treatment. The radiosensitivlty of hepal cl c7 cells was significantly decreased in the presence of DFX Conclusion: The expression of HIF-1 w by hypoxia-mimic agent DFX reduced apoptosls and radiosensitlvity in mouse hepatoma cell line hepafclc7. These results suggested that HIF-1 u could be Induced by irradiation in hypoxic ceils of tumor masses, and that this mlght Increase radioresistance in hypoxic cells.

목적: 저산소증은 방사선 감수성을 현저히 감소시키며, 이에 대한 적응 반응에서 hypoxia-inducible factor 1 $\alpha$(HIF-1 u$\alpha$가 중요한 역할을 하고 있다. HIF-1 $\alpha$의 발현과 방사선 감수성과의 상관 관계를 알아보고자 하였다. 대상 및 방법: 쥐의 간암 세포주인 hepalclc7 세포와 HIF-1 $\beta$가 결손되어 HIF-1 $\alpha$의 기능이 억제된 hepaIC4 세포를 사용했다 저산소 유사 물질인 desferrioxamine (DFX)을 전처치하고 6시간 뒤에 방사선조사를 하여 western blot으로 HIF-1 $\alpha$ 발현을 조사하였다. Apoptosis는 DNA 분절화, propidium iodide 핵염색, 그리고 apoptotic cell death detection ELISA kit를 이용하였다. MTT assay법으로 방사선 감수성을 측정하고 SF2$_{2}$ SF$_{8}$, 그리고 mean inactivation dose (MID)를 산출하여 통계적 분석을 하였다. 결과: Hepalclc7 세포에서는 DFX 전처치를 한 경우 방사선에 의해 HIF-1 $\alpha$의 발현이 증가했으나, hepalC4 세포 주에서는 변화가 없었다 Hepa1C4 세포의 방사선 감수성은 DFX처리에 따른 영향이 없었으나 hepalclc7 세포의 방사선 감수성은 DFX를 전처치했을 때 유의하게 감소하였다. 결론: 저산소 유사 물질인 DFX에 의해 유도된 HIF-1 $\alpha$가 쥐의 간암 세포주에서 apoptosis와 방사선 감수성을 감소시켰다 이러한 결과는 종괴내의 저산소 세포에서 방사선에 의해 HIF-1 $\alpha$가 유도되고 이로 인해 저산소 세포에서 방사선 감수성을 저하시키는 것으로 생각되었다.

Keywords

References

  1. Dische S. Hypoxia and local tumour control. Part 2. Radiother Oncol 1991;20:9-11 https://doi.org/10.1016/0167-8140(91)90180-O
  2. Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48:149-156 https://doi.org/10.1016/S0167-8140(98)00044-9
  3. Brizel DM, Dodge RK, Clough RW, Dewhirst MW. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53:113-117 https://doi.org/10.1016/S0167-8140(99)00102-4
  4. MacRae R, Shyr Y, Johnson D, Choy H. Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant. Radiother Oncol 2002;64:37
  5. van den Brenk HA. Hyperbaric oxygen breathing and radiation therapy. JAMA 1971;217:948-949 https://doi.org/10.1001/jama.217.7.948
  6. Coleman CN, Bump EA, Kramer RA. Chemical modifiers of cancer treatment. J Clin Oncol 1988;6:709-733 https://doi.org/10.1200/JCO.1988.6.4.709
  7. Gray LH. Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953;26:638-648 https://doi.org/10.1259/0007-1285-26-312-638
  8. Brown JM. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today 2000;6:157-162 https://doi.org/10.1016/S1357-4310(00)01677-4
  9. Wang GL, Semenza GL. General involvement of hypoxiainducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 1993;90:4304-4308 https://doi.org/10.1073/pnas.90.9.4304
  10. Aebersold DM, Burri P, Beer KT, et al. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001;61:2911-2916
  11. Zaman K, Ryu H, Hall D, et al. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J Neurosci 1999;19:9821-9830
  12. Fertil B, Dertinger H, Courdi A, Malaise EP. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat Res 1984;99:73-84 https://doi.org/10.2307/3576448
  13. Taylor J. Calculating the mean inacitvation dose [letter]. Radiat Res 1986;108:112.
  14. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68-72 https://doi.org/10.1016/S0968-0004(98)01344-9
  15. Shimoda LA, Manalo DJ, Sham JS, Semenza GL, Sylvester JT. Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol Lung Cell Mol Physiol 2001;281:L202-208 https://doi.org/10.1152/ajplung.2001.281.1.L202
  16. Semenza GL. Hypoxia-inducible factor 1: control of ox ygen homeostasis in health and disease. Pediatr Res 2001;49: 614-617 https://doi.org/10.1203/00006450-200105000-00002
  17. Hockel M, Schlenger K, Hockel S, Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 1999;59:4525-4528
  18. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-4515
  19. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999;59:5830-5835
  20. Zagzag D, Friedlander DR, Margolis B, et al. Molecular events implicated in brain tumor angiogenesis and invasion. Pediatr Neurosurg 2000;33:49-55 https://doi.org/10.1159/000028975
  21. Haugland HK, Nygaard SJ, Tysnes OB. Combined effect of alkyl-lysophospholipid and vincristine on proliferation, migration and invasion in human glioma cell lines in vitro. Anticancer Res 1999;19:149-156
  22. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000;60:4693-4696
  23. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2001;7:1661-1668
  24. Birner P, Gatterbauer B, Oberhuber G, et al. Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 2001;92:165-171 https://doi.org/10.1002/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO;2-F
  25. Troy CM, Derossi D, Prochiantz A, Greene LA, Shelanski ML. Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J Neurosci 1996;16:253-261
  26. Yonezawa M, Back SA, Gan X, Rosenberg PA, Volpe JJ. Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor. J Neurochem 1996;67:566-573 https://doi.org/10.1046/j.1471-4159.1996.67020566.x
  27. Piret JP, Mottet D, Raes M, Michiels C. Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol 2002;64:889-892
  28. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001;61:6669-6673
  29. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A 2000;97:9082-9087 https://doi.org/10.1073/pnas.97.16.9082
  30. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ, Giaccia AJ. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 1994;14:6264-6277 https://doi.org/10.1128/MCB.14.9.6264
  31. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998;392:405-408 https://doi.org/10.1038/32925
  32. Dong Z, Venkatachalam MA, Wang J, et al. Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1- independent mechanisms. J Biol Chem 2001;276:18702-18709 https://doi.org/10.1074/jbc.M011774200
  33. Baek JH, Jang JE, Kang CM, Chung, HY, Kim ND, Kim KW. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 2000;19:4621-4631 https://doi.org/10.1038/sj.onc.1203814
  34. Akakura N, Kobayashi M, Horiuchi I, et al. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 2001;61:6548-6554
  35. Kim SH, Um JH, Dong-Won B, et al. Potentiation of chemosensitivity in multidrug-resistant human leukemia CEM cells by inhibition of DNA-dependent protein kinase using wortmannin. Leuk Res 2000;24:917-925 https://doi.org/10.1016/S0145-2126(00)00061-8
  36. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002;23:687-696 https://doi.org/10.1093/carcin/23.5.687
  37. Evans AR, Limp-Foster M, Kelley MR. Going APE over ref-1. Mutat Res 2000;461:83-108 https://doi.org/10.1016/S0921-8777(00)00046-X